Report Code : CVMI24071749 | Published Date : July 16, 2024
The Poultry Vaccines Market is witnessing substantial growth, fueled by increasing poultry production, rising disease incidence, and a growing demand for antibiotic alternatives. Vaccines play a crucial role in disease prevention, performance enhancement, and compliance with global trade standards. With the poultry industry feeding billions globally, effective vaccination against diseases such as Newcastle Disease, Infectious Bursal Disease (IBD), Avian Influenza, and Marek’s Disease is critical for flock health, food safety, and economic sustainability. As of 2024, the global market is valued at USD 4.6 billion, and it is projected to reach USD 8.1 billion by 2031, growing at a CAGR of 8.1%.
Key Market Drivers
1. Growth in Global Poultry Production: Demand for affordable animal protein is rising, particularly in Asia and Africa, making vaccination a cornerstone of biosecurity.
2. Shift Toward Antibiotic-Free Production: As antibiotic growth promoters confront bans and scrutiny, vaccines are emerging as a sustainable alternative for disease control.
3. Government-Led Mass Vaccination Campaigns: National programs for avian influenza and Newcastle disease are expanding across Asia, Africa, and the Middle East.
4. Rapid Disease Detection and Surveillance Integration: Emerging diagnostic tools are facilitating more timely and targeted vaccine application.
Market Segmentation
By Disease Type
- Newcastle Disease (25%)
- Infectious Bursal Disease (IBD) (XX%)
- Marek’s Disease (XX%)
- Avian Influenza (XX%)
- Fowl Pox, E. coli, Mycoplasma, and Others (XX%)
By Vaccine Type
- Live Attenuated Vaccines (XX%)
- Inactivated (Killed) Vaccines (25%)
- Recombinant and Vector-Based Vaccines (15%)
- DNA and RNA Vaccines (XX%)
By Route of Administration
- Ocular/Nasal Drop (25%)
- Drinking Water (XX%)
- Spray/Inhalation (XX%)
- Injection (XX%)
- In Ovo and Feed-Based (XX%)
By Region
- Asia-Pacific (40%) – China, India, Indonesia lead in poultry output and vaccine usage
- North America (XX%) – Commercial broiler and layer operations driving recombinant vaccine adoption
- Europe (XX%) – High regulatory compliance and welfare-driven biosecurity
- Latin America (XX%) – Brazil and Mexico investing in AI and ND protection
- Middle East & Africa (XX%) – Growing demand for biosecure poultry protein
Competitive Landscape
Veterinary pharma companies are focused on multivalent vaccine development, thermostable formulations, and delivery innovation:
- Zoetis – Poulvac® range for Newcastle, IBD, and vector vaccines
- Boehringer Ingelheim Animal Health – VAXXITEK® and recombinant solutions
- Ceva Santé Animale – Hatchery-compatible and spray-administered vaccines
- MSD Animal Health (Merck) – Innovator in in ovo technology and ND/IBD vaccines
- Phibro Animal Health – Broad poultry vaccine portfolio with global reach
Emerging Trends
1. Hatchery-Level Vaccination and Automation: Spray cabinets, in ovo injectors, and auto-dose droplet technology are streamlining immunization at the day-old chick stage.
2. Recombinant and RNA-Based Innovations: Vector vaccines and mRNA prototypes target AI and emerging zoonoses.
3. Blockchain-Linked Vaccine Records: Farm-to-fork traceability is linked to health status and immunization data.
4. Thermostable and Low-Volume Dose Formats: Essential for mass immunization in resource-limited or hot-climate regions.
Regulatory Landscape
Vaccines must be registered with veterinary drug authorities, including the USDA (U.S.), EMA (EU), and national regulators in Asia, Africa, and Latin America. Cold chain maintenance, potency validation, and labeling for withdrawal periods are closely monitored. Export compliance for vaccinated birds requires certification, particularly for avian influenza-free status.
Reasons To Buy

Scope

Key Players
- Merck Animal Health
- Zoetis Inc.
- Ceva Santé Animale
- Boehringer Ingelheim
- Elanco Animal Health
Global Poultry Vaccines Market Report
- 1. Global Poultry Vaccines Market Research Report
- 1.1 Study Objectives
- 1.2 Global Poultry Vaccines Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Global Poultry Vaccines Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Vaccine Type
- 2.1.2 By Disease Type
- 2.1.3 By End User
- 2.1.4 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Vaccine Type, By Disease Type, By End User, By Country
- 3.3. Opportunities – By Vaccine Type, By Disease Type, By End User, By Country
- 3.4. Trends – By Vaccine Type, By Disease Type, By End User, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Global Poultry Vaccines Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Live Attenuated Vaccines
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Inactivated Vaccines
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.3 Recombinant Vaccines
- 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.4 Others
- 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Newcastle Disease
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Avian Influenza
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Marek's Disease
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.4 Others
- 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Poultry Farms
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Veterinary Hospitals
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Veterinary Clinics
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.4 Others
- 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 North America
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2 Europe
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3 Asia-Pacific
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.4 Latin America
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.5 Middle East & Africa
- 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.6 Global Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Disease Type, By End User, and Region, 2024 - 2031
- 9.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 9.1.1 Live Attenuated Vaccines
- 9.1.2 Inactivated Vaccines
- 9.1.3 Recombinant Vaccines
- 9.1.4 Others
- 9.2.1 Newcastle Disease
- 9.2.2 Avian Influenza
- 9.2.3 Marek's Disease
- 9.2.4 Others
- 9.3.1 Poultry Farms
- 9.3.2 Veterinary Hospitals
- 9.3.3 Veterinary Clinics
- 9.3.4 Others
- 9.4.1 United States
- 9.4.2 Canada
9.6 Regional Trends Analysis
9.7 North America Global Poultry Vaccines Market Research Report - Company Profiles- 9.7.1 Company 1 (United States)
- 9.7.2 Company 2 (Canada)
- 9.7.3 Company 3 (Canada)
- 10.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Live Attenuated Vaccines
- 10.1.2 Inactivated Vaccines
- 10.1.3 Recombinant Vaccines
- 10.1.4 Others
- 10.2.1 Newcastle Disease
- 10.2.2 Avian Influenza
- 10.2.3 Marek's Disease
- 10.2.4 Others
- 10.3.1 Poultry Farms
- 10.3.2 Veterinary Hospitals
- 10.3.3 Veterinary Clinics
- 10.3.4 Others
- 10.4.1 Germany
- 10.4.2 United Kingdom
- 10.4.3 France
- 10.4.4 Spain
- 10.4.5 Italy
- 10.4.6 Russia
- 10.4.7 Netherlands
- 10.4.8 Poland
- 10.4.9 Rest of Europe
10.6 Regional Trends Analysis
10.7 Europe Global Poultry Vaccines Market Research Report - Company Profiles- 10.7.1 Company 1 (Germany)
- 10.7.2 Company 2 (United Kingdom)
- 10.7.3 Company 3 (United Kingdom)
- 11.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Live Attenuated Vaccines
- 11.1.2 Inactivated Vaccines
- 11.1.3 Recombinant Vaccines
- 11.1.4 Others
- 11.2.1 Newcastle Disease
- 11.2.2 Avian Influenza
- 11.2.3 Marek's Disease
- 11.2.4 Others
- 11.3.1 Poultry Farms
- 11.3.2 Veterinary Hospitals
- 11.3.3 Veterinary Clinics
- 11.3.4 Others
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 South Korea
- 11.4.5 Australia & NZ
- 11.4.6 ASEAN
- 11.4.7 Rest of Asia-Pacific
11.6 Regional Trends Analysis
11.7 Asia-Pacific Global Poultry Vaccines Market Research Report - Company Profiles- 11.7.1 Company 1 (China)
- 11.7.2 Company 2 (Japan)
- 11.7.3 Company 3 (Japan)
- 12.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Live Attenuated Vaccines
- 12.1.2 Inactivated Vaccines
- 12.1.3 Recombinant Vaccines
- 12.1.4 Others
- 12.2.1 Newcastle Disease
- 12.2.2 Avian Influenza
- 12.2.3 Marek's Disease
- 12.2.4 Others
- 12.3.1 Poultry Farms
- 12.3.2 Veterinary Hospitals
- 12.3.3 Veterinary Clinics
- 12.3.4 Others
- 12.4.1 Brazil
- 12.4.2 Mexico
- 12.4.3 Argentina
- 12.4.4 Peru
- 12.4.5 Colombia
- 12.4.6 Rest of Latin America
12.6 Regional Trends Analysis
12.7 Latin America Global Poultry Vaccines Market Research Report - Company Profiles- 12.7.1 Company 1 (Brazil)
- 12.7.2 Company 2 (Mexico)
- 12.7.3 Company 3 (Mexico)
- 13.1 By Vaccine Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Live Attenuated Vaccines
- 13.1.2 Inactivated Vaccines
- 13.1.3 Recombinant Vaccines
- 13.1.4 Others
- 13.2.1 Newcastle Disease
- 13.2.2 Avian Influenza
- 13.2.3 Marek's Disease
- 13.2.4 Others
- 13.3.1 Poultry Farms
- 13.3.2 Veterinary Hospitals
- 13.3.3 Veterinary Clinics
- 13.3.4 Others
- 13.4.1 Saudi Arabia
- 13.4.2 UAE
- 13.4.3 South Africa
- 13.4.4 Egypt
- 13.4.5 Israel
- 13.4.6 Rest of Middle East and Africa
13.6 Regional Trends Analysis
13.7 Middle East & Africa Global Poultry Vaccines Market Research Report - Company Profiles- 13.7.1 Company 1 (Saudi Arabia)
- 13.7.2 Company 2 (UAE)
- 13.7.3 Company 3 (UAE)
- 14.1 Strategic Dashboard of Top Market Players
14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 14.2.1 Merck Animal Health
- 14.2.2 Zoetis Inc.
- 14.2.3 Ceva Santé Animale
- 14.2.4 Boehringer Ingelheim
- 14.2.5 Elanco Animal Health
16. Principal Presumptions and Acronyms